Tafenoquine for children: a step towards implementation

Tafenoquine for children: a step towards implementation

Opis bibliograficzny
Główni autorzy:	Commons, RJ, Price, RN
Format:	Journal article
Język:	English
Wydane:	Elsevier 2021

Podobne zapisy

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
od: Commons, RJ, i wsp.
Wydane: (2020)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
od: Watson, JA, i wsp.
Wydane: (2022)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis'
od: Watson, JA, i wsp.
Wydane: (2024)

Tafenoquine — a radical improvement?
od: White, N
Wydane: (2019)

The antimalarial activity of tafenoquine in falciparum malaria
od: White, NJ
Wydane: (2023)

Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
od: Geoffrey W. Birrell, i wsp.
Wydane: (2022-11-01)

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
od: Watson, JA, i wsp.
Wydane: (2021)

Tafenoquine for travelers' malaria: evidence, rationale and recommendations
od: Baird, J
Wydane: (2018)

Repurposing of the antimalarial agent tafenoquine to combat MRSA
od: Pengfei She, i wsp.
Wydane: (2023-12-01)

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
od: James A Watson, i wsp.
Wydane: (2021-05-01)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
od: James A Watson, i wsp.
Wydane: (2022-12-01)

Tafenoquine and G6PD: a primer for clinicians
od: Chu, CS, i wsp.
Wydane: (2019)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
od: James A Watson, i wsp.
Wydane: (2024-02-01)

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
od: St Jean, PL, i wsp.
Wydane: (2020)

Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria
od: Watson, J, i wsp.
Wydane: (2019)

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
od: Llanos-Cuentas, A, i wsp.
Wydane: (2019)

Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria
od: Lacerda, MVG, i wsp.
Wydane: (2019)

Pharmacokinetic Models of Tafenoquine: Insights for Optimal Malaria Treatment Strategies
od: Luisa Oliveira Santos, i wsp.
Wydane: (2024-08-01)

Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel?
od: Baird, JK
Wydane: (2021)

Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review
od: Stephan Duparc, i wsp.
Wydane: (2020-03-01)

Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection.
od: Römsing, S, i wsp.
Wydane: (2011)

Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection
od: Romsing, S, i wsp.
Wydane: (2011)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
od: Watson, J, i wsp.
Wydane: (2018)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
od: James Watson, i wsp.
Wydane: (2018-04-01)

Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria
od: Raman Sharma, i wsp.
Wydane: (2024-05-01)

Assessing tafenoquine implementation in Brazil: a qualitative evaluation of perceptions of healthcare providers and Plasmodium vivax patients (QualiTRuST Study)
od: Alicia P. C. Santos, i wsp.
Wydane: (2024-12-01)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
od: Ebstie YA, i wsp.
Wydane: (2016-07-01)

Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?
od: Amit Sharma, i wsp.
Wydane: (2021-02-01)

Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives
od: Markus MB
Wydane: (2021-09-01)

Estimating the proportion of plasmodium vivax recurrences caused by relapse: A systematic review and meta-analysis
od: Commons, RJ, i wsp.
Wydane: (2020)

Perspectives of healthcare professionals on training for quantitative G6PD testing during implementation of tafenoquine in Brazil (QualiTRuST Study)
od: Alicia Santos, i wsp.
Wydane: (2024-06-01)

Plasmodium vivax in the era of the shrinking P. falciparum map
od: Price, RN, i wsp.
Wydane: (2020)

Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo
od: Leonardo J. M. Carvalho, i wsp.
Wydane: (2020-07-01)

Extended blood stage sensitivity profiles of Plasmodium cynomolgi to doxycycline and tafenoquine, as a model for Plasmodium vivax
od: Christensen, Peter, i wsp.
Wydane: (2024)

Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone
od: Luis A. Marcos, i wsp.
Wydane: (2022-01-01)

Radical curative efficacy of tafenoquine combination regimens in <it>Plasmodium cynomolgi</it>-infected Rhesus monkeys (<it>Macaca mulatta</it>)
od: Kenworthy David, i wsp.
Wydane: (2011-07-01)

Interactions between tafenoquine and artemisinin-combination therapy partner drug in asexual and sexual stage Plasmodium falciparum
od: Karen Kemirembe, i wsp.
Wydane: (2017-08-01)

Enantiomeric resolution of primaquine, quinacrine and tafenoquine antibacterial medicines using ristocetin macrocyclic glycopeptide antibiotics CSP
od: Zeid A. ALOthman, i wsp.
Wydane: (2020-01-01)

Comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
od: Raman Sharma, i wsp.
Wydane: (2024-02-01)

A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
od: Hale, B, i wsp.
Wydane: (2003)